Dec 2021;14(12):49-54
The role of novel antidiabetic drugs in diabetic HFpEF Emerging studies indicated that the novel antidiabetic drugs, including SGLT2i, GLP-1 RA and DPP4i, provided the cardiovascular benefits in diabetic HFpEF patients [45,46,47,48,49]
Slominski A, Kim TK, Brozyna AA, Janjetovic Z, Brooks DL, Schwab LP et al
Diseases of the Central Nervous System That May Benefit from the Treatment with GLP-1RA Diabetes mellitus is one of the main risk factors for the development of cognitive dysfunction
Recomendamos que busque auxlio de seu nutricionista para que ele possa ajustar o seu protocolo adequadamente
We visit facilities, review their quality control processes, check certifications, and examine testing documentation before ever ordering patient medications